Over the past six months, our Members dedicated their expertise to publish an article on the hot topic of multiple sclerosis in individuals aged 55 and above. It was a fruitful collaboration with the European Charcot Foundation.On top of this, our Belgian colleagues discussed the important topic of differential diagnosis in MS, NMO-SD and MOGAD.With our Board we decided to work on the topic of generics, biosimilars and NBCDs for multiple sclerosis.We were also pleased to be invited to speak about AI and prognostication, smouldering disease, stem cell transplantation...
Live webinar on the use of generics, biosimilars and NBCDs for Multiple Sclerosis
On June 11th 2024, FROM 3:30 TO 4:30 PM we had the pleasure of running a highly insightful live webinar on the use of generics, biosimilars, and NBCDs for Multiple Sclerosis, led by two outstanding experts, Professor Celia Oreja-Guevara and Professor Thomas Bergen.Who attended: Neurologists, opthamologists, radiologists and other HCP as well as industry representatives from more than 30 countries.Key Takeaways:In Europe, there are robust regulatory processes specific for generics, biosimilars and follow-on NBCDs to ensure that in Europe these agents can be considered equally effective and safe...
ParadigMS at EAN Congress 2024
The 10th Congress of the European Academy of Neurology (EAN) will take place in Helsinki, Finland (and online) from 29 June to 2 July 2024.The overarching theme for EAN 2024 is ‘Neuromodulation: advances and opportunities in neurological diseases’, which will be the focus of several sessions, with something for every category of participant, from trainees to specialists, for both clinicians and scientists. The congress programme will be bursting with Symposia, Workshops, Teaching Sessions, and much more, including some exciting named Lectures from top-class line-up of speakersParadigMS...
INIC24 – The First International Neuroimmunology Conference
At the INIC24 event held on March 1st and 2nd in Riyadh, 2024, leading experts from Saudi Arabia and ParadigMS convened to explore the forefront of neuroimmunology and multiple sclerosis research.Through engaging presentations and interactive sessions, attendees gained valuable insights into cutting-edge therapies, diagnostic advancements, and optimal clinical approaches. By bringing together a variety of stakeholders, INIC24 cultivated collaboration and facilitated significant advancements in the field of neuroimmunological diseases, paving the way for a brighter future in healthcare in the...
ParadigMS Ninth Belgian Symposium 2024
On March 7th, the first successful session of the 9th Belgian Symposium took place in La Hulpe.The evening focused on the important topic of differential diagnosis in MS, NMOSD and MOGAD. Given the nature of the disease course of NMOSD and MOGAD, it is essential to quickly and accurately diagnose a patient.The participants benefited from lectures by Prof. Romain Marignier and Dr. Laurence Lutteri on Differential Diagnosis in MS, NMO-SD, MOGAD, and Advances in Clinical Techniques for CNS Inflammatory Diseases respectively. Moreover, the session saw lively discussions centered around real-life...